ClinicalTrials.Veeva

Menu

Hemodynamics, Salt Sensitivity and Body Composition in Patients With Morbid Obesity

Z

Zealand University Hospital

Status

Completed

Conditions

Hypertension
Obesity

Treatments

Other: Blood samples
Other: Echocardiography
Radiation: Dexa-scan
Dietary Supplement: Diets with low and high sodium content
Radiation: Glomerular filtration rate (GFR)
Other: Inert gas rebreathing
Other: 24-hour blood pressure
Radiation: Plasma volume
Other: Urine analyses

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to evaluate the effect of high vs. low sodium intake on blood pressure and system hemodynamics in patients with morbid obesity and to evaluate the impact of laparoscopic gastric bypass on blood pressure, salt sensitivity and body composition in morbidly obese patients. Furthermore, we wants to describe the hemodynamic mechanisms involved in the amelioration of blood pressure during long-term weight loss.

Full description

Overweight and obesity are rapidly increasing in Western countries and are associated with increased mortality and morbidity. The increased morbidity is assumed to be mediated mainly by insulin resistance, diabetes, hypertension and lipid disturbances, but obesity also represents an independent risk factor for cardiovascular disease.

Obesity is associated with an increased risk of hypertension but the pathophysiological basis is not fully established. Several studies have indicated that blood pressure of obese patients could be more dependent on dietary sodium intake than the blood pressure of non-obese patients(as it is the case for patients with essential hypertension)and that this sodium sensitivity of blood pressure is lost after weight loss.

To date, bariatric surgery is the only therapy resulting in substantial and durable long-term weight loss, and the beneficial effects on obesity-related co-morbidities have been well documented. Laparoscopic gastric bypass results in a remarkable improvement of glucose homeostasis and a resolution of diabetes, that typically occurs too fast to be accounted for by weight loss alone. Furthermore, an immediate reduction of blood pressure following laparoscopic gastric bypass has been demonstrated in morbidly obese patients with hypertension as early as one week after the operation. As with the rapid reduction of diabetes, the antihypertensive effect of the procedure might be a consequence of the rearrangement of the gastrointestinal anatomy.

With this study, we want to evaluate the effect of high vs. low sodium intake on blood pressure and system hemodynamics in patients with morbid obesity and to evaluate the impact of laparoscopic gastric bypass on blood pressure, salt sensitivity and body composition in morbidly obese patients. Furthermore, we wants to describe the hemodynamic mechanisms involved in the amelioration of blood pressure during long-term weight loss. Therefore, patients are examined before, 4-6 weeks after and one year after laparoscopic gastric bypass.

Before and one year after the operation, the patients are examined two times; in a five days period of a low dietary sodium consumption and in a five days period of a high sodium consumption respectively. Four-six weeks following the operation, the patients are examined once on their usual diet.

The protocol comprise three sub studies:

  1. The effect of high vs low sodium intake on blood pressure and hemodynamics in the morbid obese patient - preoperative study.
  2. Effect of gastric bypass surgery on blood pressure, hemodynamics and salt-sensitivity - 1 year follow-up.
  3. Effect of gastric bypass surgery on echocardiographic parameters - 1 year follow-up.

Enrollment

36 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (cases):

  • Caucasians fulfilling the criteria for laparoscopic gastric bypass.
  • 12 participants with hypertension, defined as blood pressure > 140/90 and/or use of antihypertensive medication and 12 participants without hypertension.
  • Body mass index 40-50 kg/m2

Inclusion Criteria (controls):

  • Caucasian.
  • No hypertension or use of antihypertensive medication.
  • Body mass index < 30 kg/m2

Exclusion Criteria (all):

  • Pregnancy
  • Chronic obstructive pulmonary disease
  • Diabetes mellitus
  • Medical treatment with sibutramine.

Trial design

36 participants in 3 patient groups

Obese, hypertension
Description:
Obese patients with hypertension and a body mass index 40-50 kg/m2
Treatment:
Other: 24-hour blood pressure
Radiation: Glomerular filtration rate (GFR)
Other: Urine analyses
Radiation: Plasma volume
Other: Inert gas rebreathing
Other: Blood samples
Dietary Supplement: Diets with low and high sodium content
Radiation: Dexa-scan
Other: Echocardiography
Control
Description:
Control subjects without hypertension and body mass index \< 30 kg/m2
Treatment:
Other: 24-hour blood pressure
Radiation: Glomerular filtration rate (GFR)
Other: Urine analyses
Radiation: Plasma volume
Other: Inert gas rebreathing
Other: Blood samples
Dietary Supplement: Diets with low and high sodium content
Radiation: Dexa-scan
Other: Echocardiography
Obese, normotension
Description:
Obese patients without hypertension and a BMI between 40-50 kg/m2
Treatment:
Other: 24-hour blood pressure
Radiation: Glomerular filtration rate (GFR)
Other: Urine analyses
Radiation: Plasma volume
Other: Inert gas rebreathing
Other: Blood samples
Dietary Supplement: Diets with low and high sodium content
Radiation: Dexa-scan
Other: Echocardiography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems